Update of P2Y receptor pharmacology: IUPHAR Review 27
文献类型：期刊论文
| 作者 | Jacobson, Kenneth A.4; Delicado, Esmerilda G.5; Gachet, Christian6; Kennedy, Charles7; von Kuegelgen, Ivar1; Li, Beibei8; Miras-Portugal, M. Teresa5; Novak, Ivana9; Schoeneberg, Torsten2; Perez-Sen, Raquel5 |
| 刊名 | BRITISH JOURNAL OF PHARMACOLOGY
 |
| 出版日期 | 2020-06-01 |
| 卷号 | 177期号:11页码:2413-2433 |
| ISSN号 | 0007-1188 |
| DOI | 10.1111/bph.1500510.1111/bph.15005 |
| 通讯作者 | Jacobson, Kenneth A.(kennethj@niddk.nih.gov) |
| 英文摘要 | Eight G protein-coupled P2Y receptor subtypes respond to extracellular adenine and uracil mononucleotides and dinucleotides. P2Y receptors belong to the delta group of rhodopsin-like GPCRs and contain two structurally distinct subfamilies: P2Y(1), P2Y(2), P2Y(4), P2Y(6), and P2Y(11) (principally G(q) protein-coupled P2Y(1)-like) and P2Y(12-14) (principally G(i) protein-coupled P2Y(12)-like) receptors. Brain P2Y receptors occur in neurons, glial cells, and vasculature. Endothelial P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors induce vasodilation, while smooth muscle P2Y(2), P2Y(4), and P2Y(6) receptor activation leads to vasoconstriction. Pancreatic P2Y(1) and P2Y(6) receptors stimulate while P2Y(13) receptors inhibits insulin secretion. Antagonists of P2Y(12) receptors, and potentially P2Y(1) receptors, are anti-thrombotic agents, and a P2Y(2)/P2Y(4) receptor agonist treats dry eye syndrome in Asia. P2Y receptor agonists are generally pro-inflammatory, and antagonists may eventually treat inflammatory conditions. This article reviews recent developments in P2Y receptor pharmacology (using synthetic agonists and antagonists), structure and biophysical properties (using X-ray crystallography, mutagenesis and modelling), physiological and pathophysiological roles, and present and potentially future therapeutic targeting. |
| WOS关键词 | SMOOTH-MUSCLE-CELLS ; P2Y(12) RECEPTOR ; NUCLEOTIDE RECEPTORS ; CONCISE GUIDE ; ACTIVE METABOLITE ; PURINERGIC REGULATION ; SELECTIVE AGONISTS ; EXTRACELLULAR ATP ; PLATELET P2Y(1) ; ANTAGONIST |
| 资助项目 | NIDDK[ZIADK31116] ; Independent Research Fund Denmark[DFF-4002-00162] ; State of Saxony, Germany ; Integrated Research and Treatment Center (IFB) AdiposityDiseases (BMBF) ; German Research Foundation[FOR2372] ; German Research Foundation[GRK1873] ; German Research Foundation[SFB 1052] |
| WOS研究方向 | Pharmacology & Pharmacy |
| 语种 | 英语 |
| WOS记录号 | WOS:000530811400001 |
| 出版者 | WILEY |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/280070]  |
| 专题 | 中国科学院上海药物研究所 |
| 通讯作者 | Jacobson, Kenneth A. |
| 作者单位 | 1.Univ Bonn, Dept Pharmacol & Toxicol, Biomed Res Ctr, Bonn, Germany 2.Univ Leipzig, Rudolf Schonheimer Inst Biochem, Med Fac, Mol Biochem, Leipzig, Germany 3.Univ Bonn, Pharmaceut Inst, Dept Pharmaceut & Med Chem, Bonn, Germany 4.NIDDK, Lab Bioorgan Chem, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA 5.Univ Complutense Madrid, Dept Bioquim & Biol Mol, Madrid, Spain 6.Univ Strasbourg, INSERM, EFS Grand Est, BPPS,UMR S 1255,FMTS, Strasbourg, France 7.Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland 8.Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai, Peoples R China 9.Univ Copenhagen, Sect Cell Biol & Physiol, Dept Biol, Copenhagen, Denmark 10.Univ Leipzig, IFB AdiposityDis, Med Ctr, Leipzig, Germany |
| 推荐引用方式 GB/T 7714 | Jacobson, Kenneth A.,Delicado, Esmerilda G.,Gachet, Christian,et al. Update of P2Y receptor pharmacology: IUPHAR Review 27[J]. BRITISH JOURNAL OF PHARMACOLOGY,2020,177(11):2413-2433. |
| APA | Jacobson, Kenneth A..,Delicado, Esmerilda G..,Gachet, Christian.,Kennedy, Charles.,von Kuegelgen, Ivar.,...&Mueller, Christa E..(2020).Update of P2Y receptor pharmacology: IUPHAR Review 27.BRITISH JOURNAL OF PHARMACOLOGY,177(11),2413-2433. |
| MLA | Jacobson, Kenneth A.,et al."Update of P2Y receptor pharmacology: IUPHAR Review 27".BRITISH JOURNAL OF PHARMACOLOGY 177.11(2020):2413-2433. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。